Cargando…
A Real-World Data Retrospective Cohort Study of Low Estrogen Receptor-Positive Early Breast Cancer: Natural History and Treatment Outcomes
PURPOSE: Estrogen receptor-positive (ER(+)) breast cancer (BC) is a heterogeneous disease, and there is an ongoing debate regarding the optimal cut point for clinically relevant ER expression. We used a real-world database to assess the prognostic and predictive values of lower ER expression levels...
Autores principales: | Bari, Shahla, Boulware, David, Li, Jiannong, Loftus, Loretta, Soyano Muller, Aixa, Jameel, Zena, Khong, Hung, Czerniecki, Brian J, Costa, Ricardo L B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365325/ https://www.ncbi.nlm.nih.gov/pubmed/35967746 http://dx.doi.org/10.2147/BCTT.S371975 |
Ejemplares similares
-
Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia
por: Sun, James, et al.
Publicado: (2021) -
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
por: Ahmed, Kamran A., et al.
Publicado: (2021) -
Neuroendocrine Tumor Involving the Epicardium
por: Soyano, Aixa E., et al.
Publicado: (2017) -
Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
por: Soyano, Aixa E., et al.
Publicado: (2019) -
Rifaximin for Pertuzumab-Related GI Toxicities
por: Soyano, Aixa E., et al.
Publicado: (2017)